Nomura Asset Management CO LTD Mirati Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

  • $27.2 Billion
  • Q1 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$59.5 - $86.7 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$59.5 - $86.7 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$59.5 - $86.7 $0 - $0
0 New
0 $0
Q2 2022

Aug 12, 2022
BUY
$39.16 - $88.71 $0 - $0
0 New
0 $0
Q1 2022

May 13, 2022
BUY
$75.82 - $150.97 $0 - $0
0 New
0 $0
Q4 2021

Feb 01, 2022
BUY
$132.01 - $190.29 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021
BUY
$132.13 - $177.45 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021
BUY
$144.0 - $179.73 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021
BUY
$158.92 - $221.61 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021
BUY
$162.05 - $240.27 $0 - $0
0 New
0 $0
Q3 2020

Nov 12, 2020
BUY
$113.26 - $167.27 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$72.01 - $120.39 $0 - $0
0 New
0 $0
Q1 2020

May 14, 2020
BUY
$69.78 - $116.21 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020
BUY
$70.76 - $128.86 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$77.91 - $109.6 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
BUY
$59.49 - $104.71 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019
BUY
$43.65 - $78.95 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019
BUY
$43.65 - $78.95 $0 - $0
0 New
0 $0
Q4 2018

Feb 12, 2019
BUY
$32.0 - $47.43 $0 - $0
0 New
0 $0
Q3 2018

Nov 07, 2018
BUY
$47.1 - $62.7 $0 - $0
0 New
0 $0

Others Institutions Holding MRTX

# of Institutions
19
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email